SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease

Pablo Garcia-Reitböck, Oleg Anichtchik, Arianna Bellucci, Mariangela Iovino, Chiara Ballini, Elena Fineberg, Bernardino Ghetti, Laura Della Corte, Pierfranco Spano, George K. Tofaris, Michel Goedert, Maria Grazia Spillantini

Research output: Contribution to journalArticle

138 Citations (Scopus)

Abstract

The pre-synaptic protein α-synuclein is the main component of Lewy bodies and Lewy neurites, the defining neuropathological characteristics of Parkinson's disease and dementia with Lewy bodies. Mutations in the α-synuclein gene cause familial forms of Parkinson's disease and dementia with Lewy bodies. We previously described a transgenic mouse line expressing truncated human α-synuclein(1-120) that develops α-synuclein aggregates, striatal dopamine deficiency and reduced locomotion, similar to Parkinson's disease. We now show that in the striatum of these mice, as in Parkinson's disease, synaptic accumulation of α-synuclein is accompanied by an age-dependent redistribution of the synaptic SNARE proteins SNAP-25, syntaxin-1 and synaptobrevin-2, as well as by an age-dependent reduction in dopamine release. Furthermore, the release of FM1-43 dye from PC12 cells expressing either human full-length α-synuclein(1-140) or truncated α-synuclein(1-120) was reduced. These findings reveal a novel gain of toxic function of α-synuclein at the synapse, which may be an early event in the pathogenesis of Parkinson's disease.

Original languageEnglish
Pages (from-to)2032-2044
Number of pages13
JournalBrain
Volume133
Issue number7
DOIs
StatePublished - Jul 2010

Fingerprint

Synucleins
SNARE Proteins
Transgenic Mice
Parkinson Disease
Lewy Body Disease
Dopamine
Vesicle-Associated Membrane Protein 2
Syntaxin 1
Lewy Bodies
Corpus Striatum
Poisons
PC12 Cells
Neurites
Locomotion
Synapses
Coloring Agents
Mutation

Keywords

  • alpha-synuclein
  • dopamine
  • neurodegenerative diseases
  • Parkinson's disease
  • SNARE proteins

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Garcia-Reitböck, P., Anichtchik, O., Bellucci, A., Iovino, M., Ballini, C., Fineberg, E., ... Spillantini, M. G. (2010). SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain, 133(7), 2032-2044. https://doi.org/10.1093/brain/awq132

SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. / Garcia-Reitböck, Pablo; Anichtchik, Oleg; Bellucci, Arianna; Iovino, Mariangela; Ballini, Chiara; Fineberg, Elena; Ghetti, Bernardino; Della Corte, Laura; Spano, Pierfranco; Tofaris, George K.; Goedert, Michel; Spillantini, Maria Grazia.

In: Brain, Vol. 133, No. 7, 07.2010, p. 2032-2044.

Research output: Contribution to journalArticle

Garcia-Reitböck, P, Anichtchik, O, Bellucci, A, Iovino, M, Ballini, C, Fineberg, E, Ghetti, B, Della Corte, L, Spano, P, Tofaris, GK, Goedert, M & Spillantini, MG 2010, 'SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease', Brain, vol. 133, no. 7, pp. 2032-2044. https://doi.org/10.1093/brain/awq132
Garcia-Reitböck P, Anichtchik O, Bellucci A, Iovino M, Ballini C, Fineberg E et al. SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. Brain. 2010 Jul;133(7):2032-2044. https://doi.org/10.1093/brain/awq132
Garcia-Reitböck, Pablo ; Anichtchik, Oleg ; Bellucci, Arianna ; Iovino, Mariangela ; Ballini, Chiara ; Fineberg, Elena ; Ghetti, Bernardino ; Della Corte, Laura ; Spano, Pierfranco ; Tofaris, George K. ; Goedert, Michel ; Spillantini, Maria Grazia. / SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease. In: Brain. 2010 ; Vol. 133, No. 7. pp. 2032-2044.
@article{4200aa603ed84927a9dbf70684283d82,
title = "SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease",
abstract = "The pre-synaptic protein α-synuclein is the main component of Lewy bodies and Lewy neurites, the defining neuropathological characteristics of Parkinson's disease and dementia with Lewy bodies. Mutations in the α-synuclein gene cause familial forms of Parkinson's disease and dementia with Lewy bodies. We previously described a transgenic mouse line expressing truncated human α-synuclein(1-120) that develops α-synuclein aggregates, striatal dopamine deficiency and reduced locomotion, similar to Parkinson's disease. We now show that in the striatum of these mice, as in Parkinson's disease, synaptic accumulation of α-synuclein is accompanied by an age-dependent redistribution of the synaptic SNARE proteins SNAP-25, syntaxin-1 and synaptobrevin-2, as well as by an age-dependent reduction in dopamine release. Furthermore, the release of FM1-43 dye from PC12 cells expressing either human full-length α-synuclein(1-140) or truncated α-synuclein(1-120) was reduced. These findings reveal a novel gain of toxic function of α-synuclein at the synapse, which may be an early event in the pathogenesis of Parkinson's disease.",
keywords = "alpha-synuclein, dopamine, neurodegenerative diseases, Parkinson's disease, SNARE proteins",
author = "Pablo Garcia-Reitb{\"o}ck and Oleg Anichtchik and Arianna Bellucci and Mariangela Iovino and Chiara Ballini and Elena Fineberg and Bernardino Ghetti and {Della Corte}, Laura and Pierfranco Spano and Tofaris, {George K.} and Michel Goedert and Spillantini, {Maria Grazia}",
year = "2010",
month = "7",
doi = "10.1093/brain/awq132",
language = "English",
volume = "133",
pages = "2032--2044",
journal = "Brain",
issn = "0006-8950",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson's disease

AU - Garcia-Reitböck, Pablo

AU - Anichtchik, Oleg

AU - Bellucci, Arianna

AU - Iovino, Mariangela

AU - Ballini, Chiara

AU - Fineberg, Elena

AU - Ghetti, Bernardino

AU - Della Corte, Laura

AU - Spano, Pierfranco

AU - Tofaris, George K.

AU - Goedert, Michel

AU - Spillantini, Maria Grazia

PY - 2010/7

Y1 - 2010/7

N2 - The pre-synaptic protein α-synuclein is the main component of Lewy bodies and Lewy neurites, the defining neuropathological characteristics of Parkinson's disease and dementia with Lewy bodies. Mutations in the α-synuclein gene cause familial forms of Parkinson's disease and dementia with Lewy bodies. We previously described a transgenic mouse line expressing truncated human α-synuclein(1-120) that develops α-synuclein aggregates, striatal dopamine deficiency and reduced locomotion, similar to Parkinson's disease. We now show that in the striatum of these mice, as in Parkinson's disease, synaptic accumulation of α-synuclein is accompanied by an age-dependent redistribution of the synaptic SNARE proteins SNAP-25, syntaxin-1 and synaptobrevin-2, as well as by an age-dependent reduction in dopamine release. Furthermore, the release of FM1-43 dye from PC12 cells expressing either human full-length α-synuclein(1-140) or truncated α-synuclein(1-120) was reduced. These findings reveal a novel gain of toxic function of α-synuclein at the synapse, which may be an early event in the pathogenesis of Parkinson's disease.

AB - The pre-synaptic protein α-synuclein is the main component of Lewy bodies and Lewy neurites, the defining neuropathological characteristics of Parkinson's disease and dementia with Lewy bodies. Mutations in the α-synuclein gene cause familial forms of Parkinson's disease and dementia with Lewy bodies. We previously described a transgenic mouse line expressing truncated human α-synuclein(1-120) that develops α-synuclein aggregates, striatal dopamine deficiency and reduced locomotion, similar to Parkinson's disease. We now show that in the striatum of these mice, as in Parkinson's disease, synaptic accumulation of α-synuclein is accompanied by an age-dependent redistribution of the synaptic SNARE proteins SNAP-25, syntaxin-1 and synaptobrevin-2, as well as by an age-dependent reduction in dopamine release. Furthermore, the release of FM1-43 dye from PC12 cells expressing either human full-length α-synuclein(1-140) or truncated α-synuclein(1-120) was reduced. These findings reveal a novel gain of toxic function of α-synuclein at the synapse, which may be an early event in the pathogenesis of Parkinson's disease.

KW - alpha-synuclein

KW - dopamine

KW - neurodegenerative diseases

KW - Parkinson's disease

KW - SNARE proteins

UR - http://www.scopus.com/inward/record.url?scp=77954379317&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954379317&partnerID=8YFLogxK

U2 - 10.1093/brain/awq132

DO - 10.1093/brain/awq132

M3 - Article

VL - 133

SP - 2032

EP - 2044

JO - Brain

JF - Brain

SN - 0006-8950

IS - 7

ER -